KUKJEON PHARMACEUTICAL Co.,Ltd Logo

KUKJEON PHARMACEUTICAL Co.,Ltd

A chemical solutions provider manufacturing Active Pharmaceutical Ingredients and electronic materials.

307750 | KO

Overview

Corporate Details

ISIN(s):
KR7307750000
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 학의로 282 B동 1516호 (관양동,금강펜테리움), 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the manufacture and sale of Active Pharmaceutical Ingredients (APIs) and electronic materials. With approximately 50 years of operational experience, the company has established itself as an API specialist. Its primary business involves producing and supplying raw materials for specialized medicines, including choline alfoscerates, benfothiamines, spherical sorbents, and napamostat. In addition to its pharmaceutical operations, the company develops electronic materials. Kukjeon also offers services such as molecular design and technical support, aiming to provide a comprehensive range of chemical-based products and services to its customers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 12.2 KB
2025-09-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.8 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.7 KB
2025-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-06 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.7 KB
2025-07-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 133.1 KB
2025-07-07 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 135.0 KB
2025-06-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 143.5 KB
2025-06-16 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.7 KB
2025-06-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 139.7 KB
2025-06-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 138.9 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-05-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 135.2 KB
2025-04-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 136.4 KB

Automate Your Workflow. Get a real-time feed of all KUKJEON PHARMACEUTICAL Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KUKJEON PHARMACEUTICAL Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KUKJEON PHARMACEUTICAL Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea
358570
GILEAD SCIENCES, INC. Logo
Develops innovative medicines for life-threatening diseases in virology, oncology & inflammation.
United States of America
GILD
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom
GSK
GL Pharm Tech Corp. Logo
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea
204840
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan
2160
Goodwill Pharma Plc Logo
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary
GWPH
Gossamer Bio, Inc. Logo
Clinical-stage biopharma developing inhaled therapies for rare pulmonary hypertension.
United States of America
GOSS
Grace Therapeutics, Inc. Logo
Develops improved drugs for rare neurological diseases using novel drug delivery technologies.
United States of America
GRCE
A biotech firm in biopharma, diagnostics, digital health, and consumer wellness products.
South Korea
005250
GREEN CROSS WellBeing Corporation Logo
Develops personalized nutrition solutions, from prescription injections to supplements & cosmetics.
South Korea
234690

Talk to a Data Expert

Have a question? We'll get back to you promptly.